Adicet Bio
ACET on Nasdaq. Market value $26m.
Should I look at this?
Look carefully before going further
Why it could be worth it
Nothing stands out yet.
What to watch out for
Read the warning sign in its own filings
This is not advice.
Who owns it
None of the long-term investors we follow own it. 56 funds in all.
Largest holders overall
- RA Capital Management, L.P.$8mCut
- Orbimed Advisors$7mCut
- Franklin Resources$5m
- Citadel Advisors$4mAdded
- Vanguard Capital Management$3m
- Adage Capital Partners GP, L.L.C.$2m
- Renaissance Technologies$2mAdded
- Stonepine Capital Management$2mAdded
- Alyeska Investment Group, L.P.$2m
- Schonfeld Strategic Advisors$2mNew
From 13F filings for the quarter ended 30 June 2026.
Big holders and activists
4 investors own more than 5%.
- RA Capital Management, L.P.Passive investorat least 9.9%−2.4 pts(filed with 3 related holders)Since 30 June 2026
- ORBIMED ADVISORS LLCPassive investorat least 8.8%−0.8 pts(filed with 7 related holders)Since 8 April 2026
What they said
The Reporting Persons from time to time intend to review their investment in the Issuer on the basis of various factors, including the Issuer's business, financial condition, results of operations and prospects, general economic and industry conditions, the securities markets in…
Read the filing - Franklin Templeton, Inc.Passive investorat least 7.7%+1.2 pts(filed with 3 related holders)Since 30 September 2026
- Zedek Daniel ClaytonPassive investorat least 5.4%(filed with 1 related holder)Since 19 October 2026
- Woodline Partners LPPassive investorSold down below 5%Since 31 March 2026
- TANG CAPITAL MANAGEMENT, LLCPassive investorSold down below 5%Since 31 December 2025
| Holder | Stake | Since | |
|---|---|---|---|
RA Capital Management, L.P. Passive investor | at least 9.9%−2.4 pts (filed with 3 related holders) | 30 June 2026 | |
ORBIMED ADVISORS LLC Passive investor | at least 8.8%−0.8 pts (filed with 7 related holders) | 8 April 2026 | What they saidThe Reporting Persons from time to time intend to review their investment in the Issuer on the basis of various factors, including the Issuer's business, financial condition, results of operations and prospects, general economic and industry conditions, the securities markets in… Read the filing |
Franklin Templeton, Inc. Passive investor | at least 7.7%+1.2 pts (filed with 3 related holders) | 30 September 2026 | |
Zedek Daniel Clayton Passive investor | at least 5.4% (filed with 1 related holder) | 19 October 2026 | |
Woodline Partners LP Passive investor | Sold down below 5% | 31 March 2026 | |
TANG CAPITAL MANAGEMENT, LLC Passive investor | Sold down below 5% | 31 December 2025 |
From Schedule 13D and 13G filings: anyone owning more than 5% must file one.
What insiders did
No insider bought or sold on the open market in the last 12 months.
From Form 4 filings: insiders must report trades in their own company's shares within two days.
Warning signs in its filings
Problems the company itself reported to the SEC, in its own words.
1 serious warning sign in Adicet Bio’s filings.
We look for five warning signs: doubt it can keep going, weak checks on its own accounts, a notice that its past accounts can't be relied on, a change of auditor, and one customer bringing in a big share of sales. We don't check lawsuits, investigations or debt yet.
We checked the auditor's report, internal controls, restatement notices, auditor changes and big customers in the 10-K filed 12 Mar 2026, plus the 10-Q filed 5 Nov 2026 and 9 later 8-Ks.
Doubt it can keep going
SeriousThe company or its auditor warned it may not have enough money to last the next year.
“Accordingly, the Company has concluded that substantial doubt exists about the Company’s ability to continue as a going concern.”
Show the full paragraph
Until such time as the Company can generate significant revenue from product sales, if ever, the Company expects to finance its operations through the sale of equity, debt financings, collaborative or other arrangements with corporate or other sources of financing. Adequate funding may not be available to the Company on acceptable terms or at all. The Company’s failure to raise capital as and when needed could have a negative impact on its financial condition and the Company’s ability to pursue its business strategies. Although the Company continues to pursue these plans, there is no assurance that the Company will be successful in obtaining sufficient funding on terms acceptable to the Company to fund continuing operations, if at all. If unsuccessful in raising additional capital, the Company will be required to delay, reduce the scope of, or eliminate additional research and development programs, or take other cost cutting measures, or obtain funds by sale or license of other rights to our product candidates in certain territories or indications that we would prefer to develop and commercialize ourselves. The Company expects that its current cash and cash equivalents and short-term investments may not be sufficient to fund operations for at least twelve months from the date of issuance of these unaudited consolidated financial statements. Accordingly, the Company has concluded that substantial doubt exists about the Company’s ability to continue as a going concern. The accompanying financial statements have been prepared on a going concern basis, which contemplates the realization of assets and satisfaction of liabilities in the ordinary course of business. The financial statements do not include any adjustments to the carrying amounts and classification of assets, liabilities, and reported expenses that may be necessary if the Company were unable to continue as a going concern.
From the 10-Q filed 5 November 2026, Part I, Item 1. Financial Statements. Read it in the filing
A 10-K is the yearly report every US company files with the SEC. An 8-K is a short notice of a big event.
The deep dive
Everything above is arithmetic on public filings. The deep dive reads the last ten years of annual reports, the proxy statements, and the earnings calls, then argues the case the way Buffett, Klarman, and Hohn would, and checks every claim against the source.
- What the business is worth, as a range, and the margin of safety at today’s price
- Prices to start buying, buy, and buy hard
- The three things that would make this a mistake
- Every number footnoted to the filing it came from
Your first deep dive is free.
Not advice. Numbers on this page come from SEC filings and are updated each night; prices are updated again after the US market closes. The five-year figures are rounded.